The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility
- PMID: 12408865
- DOI: 10.1016/s0092-8674(02)01012-7
The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility
Abstract
The assumption that each enzyme expresses a single enzymatic activity in vivo is challenged by the linkage of the neuronal enzyme ubiquitin C-terminal hydrolase-L1 (UCH-L1) to Parkinson's disease (PD). UCH-L1, especially those variants linked to higher susceptibility to PD, causes the accumulation of alpha-synuclein in cultured cells, an effect that cannot be explained by its recognized hydrolase activity. UCH-L1 is shown here to exhibit a second, dimerization-dependent, ubiquityl ligase activity. A polymorphic variant of UCH-L1 that is associated with decreased PD risk (S18Y) has reduced ligase activity but comparable hydrolase activity as the wild-type enzyme. Thus, the ligase activity as well as the hydrolase activity of UCH-L1 may play a role in proteasomal protein degradation, a critical process for neuronal health.
Similar articles
-
UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.J Neurochem. 2004 Jul;90(2):379-91. doi: 10.1111/j.1471-4159.2004.02485.x. J Neurochem. 2004. PMID: 15228595
-
Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.Ann Neurol. 2000 Feb;47(2):201-10. Ann Neurol. 2000. PMID: 10665491
-
Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.Biochem Biophys Res Commun. 2003 Apr 25;304(1):176-83. doi: 10.1016/s0006-291x(03)00555-2. Biochem Biophys Res Commun. 2003. PMID: 12705903
-
The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.Ann N Y Acad Sci. 2003 Jun;991:80-92. doi: 10.1111/j.1749-6632.2003.tb07465.x. Ann N Y Acad Sci. 2003. PMID: 12846976 Review.
-
[Parkinson's disease: what have we learned from the genes responsible for familial forms?].Med Sci (Paris). 2003 May;19(5):613-9. doi: 10.1051/medsci/2003195613. Med Sci (Paris). 2003. PMID: 12836396 Review. French.
Cited by
-
Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.Virchows Arch. 2013 Feb;462(2):155-61. doi: 10.1007/s00428-012-1366-0. Epub 2013 Jan 5. Virchows Arch. 2013. PMID: 23291960
-
The stromal genome heterogeneity between breast and prostate tumors revealed by a comparative transcriptomic analysis.Oncotarget. 2015 Apr 20;6(11):8687-97. doi: 10.18632/oncotarget.3478. Oncotarget. 2015. PMID: 25826086 Free PMC article.
-
Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity.J Biol Chem. 2013 May 3;288(18):12615-26. doi: 10.1074/jbc.M112.435701. Epub 2013 Mar 29. J Biol Chem. 2013. PMID: 23543736 Free PMC article.
-
Ubiquitin C-terminal hydrolase l1 in tumorigenesis.Biochem Res Int. 2012;2012:123706. doi: 10.1155/2012/123706. Epub 2012 Jul 1. Biochem Res Int. 2012. PMID: 22811913 Free PMC article.
-
Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat.Nature. 2012 Nov 15;491(7424):454-7. doi: 10.1038/nature11508. Epub 2012 Oct 14. Nature. 2012. PMID: 23064229
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
